| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.965 | 0.003 | 0.965 | Immunomodulator | 0.748 0.005 DBMET03765 | ||
| 0.696 | 0 | 0.696 | AMPA receptor agonist | 0.553 0.001 DBMET03765 0.513 0.001 DBMET03764 0.047 0.01 DBMET03766 | ||
| 0.522 | 0.035 | 0.522 | Antibacterial | 0.489 0.044 DBMET03765 0.491 0.043 DBMET03764 | ||
| 0.432 | 0.005 | 0.432 | Cell wall synthesis inhibitor | 0.277 0.012 DBMET03765 0.23 0.02 DBMET03764 0.207 0.027 DBMET03766 | ||
| 0.286 | 0.025 | 0.435 | Diuretic | 0.435 0.011 DBMET03765 0.315 0.02 DBMET03764 0.215 0.039 DBMET03766 | DBMET03765 | |
| 0.222 | 0.006 | 0.395 | Electrolyte absorption antagonist | 0.235 0.005 DBMET03765 0.395 0.003 DBMET03764 0.211 0.007 DBMET03766 | DBMET03764 | |
| 0.231 | 0.069 | 0.231 | Interleukin antagonist | |||
| 0.189 | 0.032 | 0.248 | Protein-tyrosine phosphatase 1B inhibitor | 0.188 0.033 DBMET03765 0.248 0.017 DBMET03764 | DBMET03764 | |
| 0.17 | 0.026 | 0.17 | Nav1.1 sodium channel blocker | |||
| 0.196 | 0.06 | 0.273 | Growth hormone agonist | 0.167 0.075 DBMET03765 0.273 0.038 DBMET03764 0.159 0.08 DBMET03766 | DBMET03764 | |
| 0.143 | 0.019 | 0.157 | Glutamate receptor agonist | 0.089 0.045 DBMET03765 0.157 0.016 DBMET03764 | DBMET03764 | |
| 0.233 | 0.123 | 0.553 | Nootropic | 0.553 0.014 DBMET03764 | DBMET03764 | |
| 0.199 | 0.105 | 0.622 | Aldehyde oxidase inhibitor | 0.19 0.11 DBMET03765 0.302 0.066 DBMET03764 0.622 0.016 DBMET03766 | DBMET03766 | |
| 0.158 | 0.071 | 0.279 | Protein-tyrosine phosphatase inhibitor | 0.163 0.067 DBMET03765 0.279 0.023 DBMET03764 | DBMET03764 | |
| 0.183 | 0.099 | 0.267 | 5 Hydroxytryptamine 3E antagonist | 0.205 0.054 DBMET03764 0.267 0.01 DBMET03766 | DBMET03766 | |
| 0.093 | 0.029 | 0.257 | Carbonic anhydrase inhibitor | 0.187 0.011 DBMET03764 0.257 0.005 DBMET03766 | DBMET03766 | |
| 0.1 | 0.037 | 0.116 | Factor XII inhibitor | 0.08 0.066 DBMET03765 0.116 0.025 DBMET03764 | DBMET03764 | |
| 0.202 | 0.147 | 0.311 | 5 Hydroxytryptamine uptake stimulant | 0.247 0.084 DBMET03764 0.311 0.039 DBMET03766 | DBMET03766 | |
| 0.123 | 0.075 | 0.168 | Alpha-N-acetylglucosaminidase inhibitor | 0.127 0.071 DBMET03765 0.15 0.055 DBMET03764 0.168 0.046 DBMET03766 | DBMET03766 | |
| 0.048 | 0.006 | 0.052 | HCV polyprotein inhibitor | 0.048 0.005 DBMET03765 0.052 0.005 DBMET03764 | DBMET03764 | |
| 0.07 | 0.029 | 0.103 | Cathepsin D inhibitor | 0.061 0.034 DBMET03765 0.103 0.017 DBMET03764 | DBMET03764 | |
| 0.102 | 0.065 | 0.345 | Carbonic anhydrase XV inhibitor | 0.089 0.085 DBMET03765 0.127 0.042 DBMET03764 0.345 0.005 DBMET03766 | DBMET03766 | |
| 0.081 | 0.049 | 0.081 | Focal adhesion kinase 1 inhibitor | |||
| 0.049 | 0.019 | 0.095 | DNA gyrase subunit A inhibitor | 0.042 0.029 DBMET03765 0.095 0.004 DBMET03764 | DBMET03764 | |
| 0.036 | 0.017 | 0.042 | HCV NS5B polymerase inhibitor | 0.038 0.015 DBMET03765 0.042 0.013 DBMET03764 | DBMET03764 | |
| 0.078 | 0.06 | 0.47 | Carbonic anhydrase VI inhibitor | 0.119 0.03 DBMET03764 0.47 0.004 DBMET03766 | DBMET03766 | |
| 0.09 | 0.072 | 0.09 | Interleukin 12 antagonist | |||
| 0.053 | 0.037 | 0.18 | Aldose reductase inhibitor | 0.18 0.008 DBMET03765 0.076 0.025 DBMET03764 | DBMET03765 | |
| 0.091 | 0.077 | 0.356 | GABA C receptor agonist | 0.095 0.072 DBMET03765 0.146 0.035 DBMET03764 0.356 0.006 DBMET03766 | DBMET03766 | |
| 0.052 | 0.043 | 0.207 | Carbonic anhydrase VB inhibitor | 0.075 0.025 DBMET03764 0.207 0.005 DBMET03766 | DBMET03766 | |
| 0.023 | 0.013 | 0.023 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.056 | 0.05 | 0.056 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.051 | 0.054 | 0.123 | Carbamoyl phosphate synthetase inhibitor | 0.056 0.047 DBMET03764 0.123 0.015 DBMET03766 | DBMET03766 | |
| 0.045 | 0.049 | 0.224 | Carbonic anhydrase II inhibitor | 0.088 0.022 DBMET03764 0.224 0.005 DBMET03766 | DBMET03766 | |
| 0.043 | 0.049 | 0.052 | HCV NS3/NS4A protease inhibitor | 0.052 0.03 DBMET03764 | DBMET03764 | |
| 0.162 | 0.17 | 0.209 | RNA-directed DNA polymerase inhibitor | 0.209 0.088 DBMET03765 0.202 0.097 DBMET03764 | DBMET03765 | |
| 0.059 | 0.071 | 0.11 | Aminopeptidase I inhibitor | 0.065 0.061 DBMET03764 0.11 0.023 DBMET03766 | DBMET03766 | |
| 0.045 | 0.061 | 0.092 | Tyk2 inhibitor | 0.092 0.031 DBMET03764 | DBMET03764 | |
| 0.136 | 0.153 | 0.158 | Focal adhesion kinase 2 inhibitor | 0.158 0.117 DBMET03764 | DBMET03764 | |
| 0.056 | 0.075 | 0.251 | Carbonic anhydrase XIII inhibitor | 0.085 0.046 DBMET03764 0.251 0.009 DBMET03766 | DBMET03766 | |
| 0.036 | 0.058 | 0.206 | Carbonic anhydrase I inhibitor | 0.057 0.037 DBMET03764 0.206 0.006 DBMET03766 | DBMET03766 | |
| 0.048 | 0.072 | 0.296 | Carbonic anhydrase V inhibitor | 0.071 0.042 DBMET03764 0.296 0.004 DBMET03766 | DBMET03766 | |
| 0.039 | 0.063 | 0.059 | Dopamine beta hydroxylase inhibitor | 0.059 0.016 DBMET03766 | DBMET03766 | |
| 0.052 | 0.076 | 0.259 | Carbonic anhydrase VA inhibitor | 0.071 0.044 DBMET03764 0.259 0.004 DBMET03766 | DBMET03766 | |
| 0.008 | 0.038 | 0.054 | Carbonic anhydrase VIII inhibitor | 0.054 0.002 DBMET03766 | DBMET03766 | |
| 0.008 | 0.038 | 0.054 | Carbonic anhydrase X inhibitor | 0.054 0.002 DBMET03766 | DBMET03766 | |
| 0.05 | 0.083 | 0.057 | Ryanodine receptor antagonist | 0.057 0.049 DBMET03764 | DBMET03764 | |
| 0.023 | 0.058 | 0.028 | DNA topoisomerase IV inhibitor | 0.028 0.026 DBMET03764 | DBMET03764 | |
| 0.08 | 0.117 | 0.173 | Adenylate kinase inhibitor | 0.173 0.02 DBMET03766 | DBMET03766 | |
| 0.188 | 0.232 | 0.276 | Calcium channel activator | 0.276 0.117 DBMET03764 0.219 0.187 DBMET03766 | DBMET03764 | |
| 0.052 | 0.099 | 0.074 | Secretase beta inhibitor | 0.074 0.043 DBMET03764 | DBMET03764 | |
| 0.013 | 0.06 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.012 DBMET03766 | DBMET03766 | |
| 0.031 | 0.081 | 0.112 | Acyl-CoA dehydrogenase inhibitor | 0.112 0.014 DBMET03766 | DBMET03766 | |
| 0.053 | 0.104 | 0.066 | Exportin-1 inhibitor | 0.066 0.054 DBMET03766 | DBMET03766 | |
| 0.033 | 0.085 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.042 DBMET03766 | DBMET03766 | |
| 0.022 | 0.074 | 0.047 | Oxytocin agonist | 0.039 0.033 DBMET03764 0.047 0.026 DBMET03766 | DBMET03766 | |
| 0.065 | 0.118 | 0.105 | NADH dehydrogenase inhibitor | 0.105 0.039 DBMET03766 | DBMET03766 | |
| 0.163 | 0.218 | 0.254 | Tyrosine 3 hydroxylase inhibitor | 0.198 0.14 DBMET03764 0.254 0.064 DBMET03766 | DBMET03766 | |
| 0.021 | 0.076 | 0.14 | Carbonic anhydrase VII inhibitor | 0.14 0.007 DBMET03766 | DBMET03766 | |
| 0.049 | 0.107 | 0.186 | Glutamate dehydrogenase inhibitor | 0.186 0.011 DBMET03766 | DBMET03766 | |
| 0.027 | 0.085 | 0.177 | Carbonic anhydrase XIV inhibitor | 0.177 0.005 DBMET03766 | DBMET03766 | |
| 0.028 | 0.096 | 0.047 | Kainate receptor agonist | 0.047 0.018 DBMET03766 | DBMET03766 | |
| 0.119 | 0.191 | 0.133 | Ca2+-transporting ATPase inhibitor | 0.133 0.104 DBMET03766 | DBMET03766 | |
| 0.017 | 0.094 | 0.068 | Secretase gamma inhibitor | 0.068 0.014 DBMET03764 | DBMET03764 | |
| 0.03 | 0.109 | 0.055 | Alpha-mannosidase inhibitor | 0.055 0.035 DBMET03766 | DBMET03766 | |
| 0.005 | 0.086 | 0.031 | Aminopeptidase A inhibitor | 0.031 0.006 DBMET03766 | DBMET03766 | |
| 0.014 | 0.097 | 0.169 | Carbonic anhydrase XII inhibitor | 0.067 0.03 DBMET03764 0.169 0.01 DBMET03766 | DBMET03766 | |
| 0.031 | 0.114 | 0.049 | Potassium channel (Inward rectifier) activator | 0.049 0.038 DBMET03764 | DBMET03764 | |
| 0.17 | 0.252 | 0.319 | GABA C receptor rho-3 antagonist | 0.242 0.161 DBMET03764 0.319 0.103 DBMET03766 | DBMET03766 | |
| 0.014 | 0.097 | 0.177 | Carbonic anhydrase IX inhibitor | 0.073 0.03 DBMET03764 0.177 0.01 DBMET03766 | DBMET03766 | |
| 0.03 | 0.114 | 0.046 | Potassium channel (ATP-sensitive) activator | 0.046 0.038 DBMET03764 | DBMET03764 | |
| 0.018 | 0.102 | 0.04 | Dipeptidyl peptidase II inhibitor | 0.04 0.014 DBMET03766 | DBMET03766 | |
| 0.023 | 0.109 | 0.038 | Glutamate (mGluR8) agonist | 0.038 0.026 DBMET03766 | DBMET03766 | |
| 0.02 | 0.106 | 0.133 | Ornithine carbamoyltransferase inhibitor | 0.133 0.011 DBMET03766 | DBMET03766 | |
| 0.004 | 0.091 | 0.021 | Carbonic anhydrase XI inhibitor | 0.021 0.004 DBMET03766 | DBMET03766 | |
| 0.057 | 0.146 | 0.1 | Triose-phosphate isomerase inhibitor | 0.1 0.048 DBMET03766 | DBMET03766 | |
| 0.092 | 0.182 | 0.126 | Cyclin-dependent kinase 8 inhibitor | 0.126 0.108 DBMET03764 | DBMET03764 | |
| 0.03 | 0.128 | 0.061 | CXC chemokine 1 receptor antagonist | 0.061 0.02 DBMET03765 | DBMET03765 | |
| 0.02 | 0.118 | 0.049 | Mannosidase inhibitor | 0.049 0.026 DBMET03766 | DBMET03766 | |
| 0.006 | 0.107 | 0.082 | Arginase inhibitor | 0.082 0.005 DBMET03766 | DBMET03766 | |
| 0.027 | 0.131 | 0.082 | Phosphofructokinase-1 inhibitor | 0.082 0.04 DBMET03766 | DBMET03766 | |
| 0.016 | 0.122 | 0.044 | Dopamine D5 agonist | 0.044 0.022 DBMET03766 | DBMET03766 | |
| 0.035 | 0.14 | 0.179 | Glutamate decarboxylase inhibitor | 0.179 0.009 DBMET03766 | DBMET03766 | |
| 0.076 | 0.181 | 0.13 | Interleukin 8 antagonist | 0.101 0.094 DBMET03765 0.108 0.08 DBMET03764 0.13 0.05 DBMET03766 | DBMET03766 | |
| 0.046 | 0.152 | 0.178 | Aminopeptidase B inhibitor | 0.178 0.027 DBMET03766 | DBMET03766 | |
| 0.134 | 0.241 | 0.433 | DNA synthesis inhibitor | 0.189 0.14 DBMET03765 0.177 0.158 DBMET03764 0.433 0.018 DBMET03766 | DBMET03766 | |
| 0.009 | 0.117 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.024 0.014 DBMET03766 | DBMET03766 | |
| 0.108 | 0.215 | 0.195 | Succinate dehydrogenase inhibitor | 0.195 0.053 DBMET03766 | DBMET03766 | |
| 0.014 | 0.121 | 0.027 | 5 Hydroxytryptamine 6 agonist | 0.027 0.023 DBMET03766 | DBMET03766 | |
| 0.009 | 0.12 | 0.031 | Lysine carboxypeptidase inhibitor | 0.031 0.015 DBMET03766 | DBMET03766 | |
| 0.097 | 0.21 | 0.51 | Anticonvulsant | 0.51 0.011 DBMET03766 | DBMET03766 | |
| 0.015 | 0.134 | 0.028 | Complement factor 1s inhibitor | 0.028 0.011 DBMET03766 | DBMET03766 | |
| 0.052 | 0.172 | 0.09 | UDP-glucose 4-epimerase inhibitor | 0.09 0.073 DBMET03766 | DBMET03766 | |
| 0.029 | 0.15 | 0.089 | Alpha adrenoreceptor agonist | 0.089 0.033 DBMET03764 0.061 0.054 DBMET03766 | DBMET03764 | |
| 0.091 | 0.213 | 0.155 | Adenylate cyclase stimulant | 0.155 0.055 DBMET03766 | DBMET03766 | |
| 0.051 | 0.176 | 0.134 | Ferrochelatase inhibitor | 0.134 0.045 DBMET03766 | DBMET03766 | |
| 0.012 | 0.139 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.019 DBMET03766 | DBMET03766 | |
| 0.009 | 0.136 | 0.136 | Carbonic anhydrase IV inhibitor | 0.136 0.004 DBMET03766 | DBMET03766 | |
| 0.023 | 0.153 | 0.056 | Biliverdin reductase inhibitor | 0.056 0.045 DBMET03766 | DBMET03766 | |
| 0.046 | 0.182 | 0.129 | Creatine kinase inhibitor | 0.129 0.035 DBMET03766 | DBMET03766 | |
| 0.012 | 0.151 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.021 DBMET03766 | DBMET03766 | |
| 0.016 | 0.155 | 0.043 | Membrane dipeptidase inhibitor | 0.043 0.022 DBMET03766 | DBMET03766 | |
| 0.118 | 0.257 | 0.285 | 5 Hydroxytryptamine release stimulant | 0.17 0.153 DBMET03764 0.285 0.075 DBMET03766 | DBMET03766 | |
| 0.049 | 0.188 | 0.083 | GABA B receptor agonist | 0.083 0.037 DBMET03766 | DBMET03766 | |
| 0.007 | 0.147 | 0.029 | Glutamate (mGluR1a) agonist | 0.029 0.009 DBMET03766 | DBMET03766 | |
| 0.054 | 0.196 | 0.21 | GABA C receptor antagonist | 0.21 0.011 DBMET03766 | DBMET03766 | |
| 0.013 | 0.157 | 0.045 | Alpha 1d adrenoreceptor agonist | 0.045 0.02 DBMET03766 | DBMET03766 | |
| 0.042 | 0.186 | 0.063 | Glutamate (mGluR6) antagonist | 0.063 0.058 DBMET03766 | DBMET03766 | |
| 0.014 | 0.159 | 0.034 | Factor XIIIa inhibitor | 0.034 0.03 DBMET03766 | DBMET03766 | |
| 0.045 | 0.19 | 0.084 | Prolactin inhibitor | 0.084 0.075 DBMET03766 | DBMET03766 | |
| 0.023 | 0.171 | 0.047 | Aconitate hydratase inhibitor | 0.047 0.044 DBMET03766 | DBMET03766 | |
| 0.03 | 0.18 | 0.091 | NMDA receptor agonist | 0.058 0.05 DBMET03764 0.091 0.023 DBMET03766 | DBMET03766 | |
| 0.035 | 0.186 | 0.093 | Metalloproteinase-9 inhibitor | 0.093 0.036 DBMET03766 | DBMET03766 | |
| 0.013 | 0.167 | 0.054 | Matrix metalloproteinase 1 inhibitor | 0.054 0.036 DBMET03766 | DBMET03766 | |
| 0.032 | 0.189 | 0.089 | Metalloproteinase-2 inhibitor | 0.089 0.045 DBMET03766 | DBMET03766 | |
| 0.025 | 0.187 | 0.125 | Porphobilinogen synthase inhibitor | 0.125 0.027 DBMET03766 | DBMET03766 | |
| 0.024 | 0.187 | 0.132 | Phenylalanine 4-hydroxylase inhibitor | 0.132 0.015 DBMET03766 | DBMET03766 | |
| 0.018 | 0.186 | 0.084 | Alcohol oxidase inhibitor | 0.084 0.023 DBMET03766 | DBMET03766 | |
| 0.024 | 0.192 | 0.108 | Carbonic anhydrase stimulant | 0.108 0.017 DBMET03766 | DBMET03766 | |
| 0.017 | 0.187 | 0.05 | Argininosuccinate synthase inhibitor | 0.05 0.047 DBMET03766 | DBMET03766 | |
| 0.051 | 0.222 | 0.097 | Mucolytic | 0.097 0.081 DBMET03766 | DBMET03766 | |
| 0.063 | 0.235 | 0.324 | Peroxidase inhibitor | 0.324 0.033 DBMET03766 | DBMET03766 | |
| 0.022 | 0.194 | 0.083 | Matrix metalloproteinase inhibitor | 0.083 0.035 DBMET03766 | DBMET03766 | |
| 0.057 | 0.231 | 0.097 | CC chemokine 5 receptor agonist | 0.097 0.025 DBMET03766 | DBMET03766 | |
| 0.125 | 0.308 | 0.183 | Nitric-oxide synthase stimulant | 0.183 0.12 DBMET03766 | DBMET03766 | |
| 0.024 | 0.209 | 0.067 | Na+ K+ transporting ATPase inhibitor | 0.067 0.063 DBMET03766 | DBMET03766 | |
| 0.013 | 0.199 | 0.035 | Carboxypeptidase B inhibitor | 0.035 0.02 DBMET03766 | DBMET03766 | |
| 0.034 | 0.221 | 0.084 | Inducible nitric-oxide synthase inhibitor | 0.084 0.055 DBMET03766 | DBMET03766 | |
| 0.009 | 0.196 | 0.053 | Glycine transporter inhibitor | 0.053 0.029 DBMET03766 | DBMET03766 | |
| 0.009 | 0.199 | 0.052 | Dihydropteroate synthase inhibitor | 0.052 0.016 DBMET03766 | DBMET03766 | |
| 0.107 | 0.298 | 0.151 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.151 0.146 DBMET03766 | DBMET03766 | |
| 0.037 | 0.233 | 0.077 | Histamine H2 receptor antagonist | 0.077 0.071 DBMET03766 | DBMET03766 | |
| 0.041 | 0.237 | 0.104 | Nitric-oxide synthase inhibitor | 0.104 0.054 DBMET03766 | DBMET03766 | |
| 0.014 | 0.213 | 0.079 | Histamine H2 receptor agonist | 0.079 0.007 DBMET03766 | DBMET03766 | |
| 0.036 | 0.237 | 0.104 | Glycine receptor agonist | 0.104 0.019 DBMET03766 | DBMET03766 | |
| 0.193 | 0.396 | 0.287 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.287 0.231 DBMET03766 | DBMET03766 | |
| 0.045 | 0.253 | 0.278 | Carbonic anhydrase III inhibitor | 0.278 0.007 DBMET03766 | DBMET03766 | |
| 0.014 | 0.226 | 0.039 | AMPA 4 receptor antagonist | 0.039 0.029 DBMET03766 | DBMET03766 | |
| 0.042 | 0.26 | 0.128 | GABA C receptor rho-1 antagonist | 0.128 0.033 DBMET03766 | DBMET03766 | |
| 0.005 | 0.226 | 0.051 | Glycine transporter 1 inhibitor | 0.051 0.015 DBMET03766 | DBMET03766 | |
| 0.04 | 0.269 | 0.084 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.084 0.074 DBMET03766 | DBMET03766 | |
| 0.008 | 0.239 | 0.053 | Factor Xa inhibitor | 0.053 0.027 DBMET03766 | DBMET03766 | |
| 0.014 | 0.246 | 0.044 | Histamine H1 receptor agonist | 0.044 0.03 DBMET03766 | DBMET03766 | |
| 0.026 | 0.261 | 0.072 | GABA aminotransferase inhibitor | 0.072 0.058 DBMET03766 | DBMET03766 | |
| 0.018 | 0.26 | 0.098 | Cytokine production stimulant | 0.098 0.004 DBMET03766 | DBMET03766 | |
| 0.02 | 0.264 | 0.043 | Glutamate (mGluR4) antagonist | 0.043 0.031 DBMET03766 | DBMET03766 | |
| 0.003 | 0.249 | 0.06 | 5 Hydroxytryptamine 1D agonist | 0.06 0.008 DBMET03766 | DBMET03766 | |
| 0.007 | 0.258 | 0.068 | Calcium-sensing receptor agonist | 0.068 0.004 DBMET03766 | DBMET03766 | |
| 0.079 | 0.335 | 0.189 | Phospholipase C inhibitor | 0.189 0.052 DBMET03766 | DBMET03766 | |
| 0.024 | 0.28 | 0.097 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.097 0.016 DBMET03766 | DBMET03766 | |
| 0.047 | 0.307 | 0.106 | Aldehyde dehydrogenase inhibitor | 0.106 0.088 DBMET03766 | DBMET03766 | |
| 0.04 | 0.3 | 0.074 | MAP kinase kinase 7 inhibitor | 0.074 0.067 DBMET03766 | DBMET03766 | |
| 0.072 | 0.349 | 0.199 | 5 Hydroxytryptamine 1E antagonist | 0.199 0.132 DBMET03766 | DBMET03766 | |
| 0.017 | 0.296 | 0.055 | CC chemokine 4 receptor antagonist | 0.055 0.021 DBMET03766 | DBMET03766 | |
| 0.015 | 0.295 | 0.064 | Catalase inhibitor | 0.064 0.061 DBMET03766 | DBMET03766 | |
| 0.004 | 0.285 | 0.038 | Histamine H4 receptor agonist | 0.038 0.005 DBMET03766 | DBMET03766 | |
| 0.013 | 0.294 | 0.074 | Alpha 2 adrenoreceptor agonist | 0.074 0.028 DBMET03766 | DBMET03766 | |
| 0.024 | 0.31 | 0.108 | Histamine N-methyltransferase inhibitor | 0.108 0.039 DBMET03766 | DBMET03766 | |
| 0.016 | 0.303 | 0.089 | Histidine decarboxylase inhibitor | 0.089 0.037 DBMET03766 | DBMET03766 | |
| 0.013 | 0.302 | 0.064 | Elastase inhibitor | 0.064 0.027 DBMET03765 | DBMET03765 | |
| 0.026 | 0.322 | 0.099 | Urease inhibitor | 0.099 0.068 DBMET03766 | DBMET03766 | |
| 0.043 | 0.348 | 0.172 | Anesthetic general | 0.172 0.093 DBMET03766 | DBMET03766 | |
| 0.031 | 0.337 | 0.188 | Sodium channel (voltage-gated) blocker | 0.188 0.034 DBMET03766 | DBMET03766 | |
| 0.009 | 0.317 | 0.062 | 5 Hydroxytryptamine 4 antagonist | 0.062 0.022 DBMET03766 | DBMET03766 | |
| 0.013 | 0.323 | 0.056 | Phenylethanolamine N methyltransferase inhibitor | 0.056 0.01 DBMET03764 0.04 0.029 DBMET03766 | DBMET03764 | |
| 0.029 | 0.347 | 0.09 | 5 Hydroxytryptamine 3A agonist | 0.09 0.089 DBMET03766 | DBMET03766 | |
| 0.024 | 0.353 | 0.089 | Somatostatin 1 agonist | 0.089 0.042 DBMET03766 | DBMET03766 | |
| 0.005 | 0.336 | 0.04 | Protease activated receptor 1 antagonist | 0.04 0.037 DBMET03764 | DBMET03764 | |
| 0.036 | 0.369 | 0.065 | MDM2 inhibitor | 0.065 0.053 DBMET03766 | DBMET03766 | |
| 0.013 | 0.349 | 0.052 | Beta 1 adrenoreceptor antagonist | 0.052 0.044 DBMET03766 | DBMET03766 | |
| 0.086 | 0.434 | 0.228 | Insulysin inhibitor | 0.228 0.119 DBMET03766 | DBMET03766 | |
| 0.066 | 0.425 | 0.254 | Superoxide dismutase inhibitor | 0.254 0.072 DBMET03766 | DBMET03766 | |
| 0.007 | 0.366 | 0.042 | Thymidylate synthase inhibitor | 0.042 0.039 DBMET03766 | DBMET03766 | |
| 0.024 | 0.387 | 0.071 | Trypsin inhibitor | 0.071 0.033 DBMET03766 | DBMET03766 | |
| 0.014 | 0.388 | 0.055 | Epithelial sodium channel blocker | 0.055 0.036 DBMET03766 | DBMET03766 | |
| 0.01 | 0.384 | 0.074 | Nav1.7 sodium channel blocker | 0.074 0.039 DBMET03766 | DBMET03766 | |
| 0.012 | 0.394 | 0.061 | Beta 2 adrenoreceptor antagonist | 0.061 0.023 DBMET03766 | DBMET03766 | |
| 0.024 | 0.411 | 0.147 | Sodium channel blocker | 0.147 0.06 DBMET03766 | DBMET03766 | |
| 0.015 | 0.409 | 0.089 | Beta adrenoreceptor antagonist | 0.089 0.021 DBMET03766 | DBMET03766 | |
| 0.016 | 0.411 | 0.082 | Adrenaline agonist | 0.082 0.054 DBMET03766 | DBMET03766 | |
| 0.023 | 0.426 | 0.15 | MAP kinase kinase 1 inhibitor | 0.15 0.017 DBMET03766 | DBMET03766 | |
| 0.016 | 0.422 | 0.234 | Alkylator | 0.234 0.019 DBMET03766 | DBMET03766 | |
| 0.019 | 0.435 | 0.086 | Myeloperoxidase inhibitor | 0.086 0.055 DBMET03766 | DBMET03766 | |
| 0.007 | 0.456 | 0.131 | Histamine agonist | 0.131 0.005 DBMET03766 | DBMET03766 | |
| 0.009 | 0.46 | 0.054 | Histamine H4 receptor antagonist | 0.054 0.024 DBMET03766 | DBMET03766 | |
| 0.014 | 0.473 | 0.066 | Beta 2 adrenoreceptor agonist | 0.066 0.029 DBMET03766 | DBMET03766 | |
| 0.012 | 0.484 | 0.131 | I kappa B kinase 2 inhibitor | 0.131 0.007 DBMET03766 | DBMET03766 | |
| 0.004 | 0.481 | 0.039 | Purinergic P2Y antagonist | 0.039 0.037 DBMET03766 | DBMET03766 | |
| 0.011 | 0.505 | 0.112 | Alcohol dehydrogenase inhibitor | 0.112 0.041 DBMET03766 | DBMET03766 | |
| 0.027 | 0.53 | 0.115 | Sphingosine 1-phosphate receptor 2 antagonist | 0.115 0.111 DBMET03766 | DBMET03766 | |
| 0.012 | 0.52 | 0.159 | MAP kinase kinase inhibitor | 0.159 0.047 DBMET03766 | DBMET03766 | |
| 0.004 | 0.524 | 0.141 | Cannabinoid CB1 receptor agonist | 0.141 0.011 DBMET03766 | DBMET03766 | |
| 0.004 | 0.536 | 0.081 | Cannabinoid receptor agonist | 0.081 0.035 DBMET03766 | DBMET03766 | |
| 0.038 | 0.581 | 0.135 | CF transmembrane conductance regulator agonist | 0.135 0.107 DBMET03766 | DBMET03766 | |
| 0.074 | 0.638 | 0.168 | Heat shock protein 70 antagonist | 0.168 0.019 DBMET03766 | DBMET03766 | |
| 0.006 | 0.586 | 0.042 | Carbonic anhydrase I stimulant | 0.042 0.021 DBMET03766 | DBMET03766 | |
| 0.01 | 0.605 | 0.161 | I kappa B kinase inhibitor | 0.161 0.014 DBMET03766 | DBMET03766 | |
| 0.007 | 0.609 | 0.102 | HIV-1 integrase inhibitor | 0.102 0.024 DBMET03765 | DBMET03765 | |
| 0.003 | 0.626 | 0.062 | Vasopressin 1B antagonist | 0.062 0.005 DBMET03766 | DBMET03766 | |
| 0.015 | 0.643 | 0.087 | Carbonic anhydrase II stimulant | 0.087 0.007 DBMET03766 | DBMET03766 | |
| 0.006 | 0.637 | 0.105 | Cyclin-dependent kinase 9 inhibitor | 0.105 0.058 DBMET03766 | DBMET03766 | |
| 0.044 | 0.693 | 0.264 | Sodium/bile acid cotransporter inhibitor | 0.264 0.113 DBMET03766 | DBMET03766 | |
| 0.005 | 0.655 | 0.078 | Vasopressin 2 antagonist | 0.078 0.008 DBMET03764 0.064 0.01 DBMET03766 | DBMET03764 | |
| 0.026 | 0.688 | 0.106 | Transcription factor STAT6 inhibitor | 0.106 0.09 DBMET03766 | DBMET03766 | |
| 0.015 | 0.68 | 0.05 | Vanilloid 2 antagonist | 0.05 0.041 DBMET03766 | DBMET03766 | |
| 0.007 | 0.687 | 0.058 | Lysine-specific demethylase 1A inhibitor | 0.058 0.031 DBMET03766 | DBMET03766 | |
| 0.014 | 0.723 | 0.186 | Antipruritic | 0.186 0.059 DBMET03766 | DBMET03766 | |
| 0.037 | 0.749 | 0.199 | MAP kinase kinase 4 inhibitor | 0.199 0.014 DBMET03766 | DBMET03766 | |
| 0.008 | 0.721 | 0.272 | Cyclooxygenase inhibitor | 0.272 0.022 DBMET03766 | DBMET03766 | |
| 0.004 | 0.734 | 0.072 | Oxytocin antagonist | 0.072 0.013 DBMET03764 0.038 0.026 DBMET03766 | DBMET03764 | |
| 0.005 | 0.756 | 0.28 | Cyclooxygenase 2 inhibitor | 0.28 0.016 DBMET03766 | DBMET03766 | |
| 0.006 | 0.76 | 0.205 | Cyclooxygenase 1 inhibitor | 0.205 0.032 DBMET03766 | DBMET03766 | |
| 0.004 | 0.759 | 0.085 | HIV-1 integrase (3'-Processing) inhibitor | 0.085 0.032 DBMET03765 | DBMET03765 | |
| 0.011 | 0.767 | 0.229 | Transcription factor STAT3 inhibitor | 0.229 0.103 DBMET03766 | DBMET03766 | |
| 0.002 | 0.782 | 0.046 | Estrone sulfatase inhibitor | 0.046 0.008 DBMET03766 | DBMET03766 | |
| 0.031 | 0.823 | 0.116 | Factor V inhibitor | 0.116 0.043 DBMET03766 | DBMET03766 | |
| 0.009 | 0.801 | 0.243 | DNA directed RNA polymerase inhibitor | 0.243 0.009 DBMET03766 | DBMET03766 | |
| 0.008 | 0.808 | 0.384 | I kappa B kinase 1 inhibitor | 0.384 0.003 DBMET03766 | DBMET03766 | |
| 0.011 | 0.815 | 0.22 | Transcription factor STAT inhibitor | 0.22 0.112 DBMET03766 | DBMET03766 | |
| 0.004 | 0.817 | 0.056 | Protein kinase C eta inhibitor | 0.056 0.037 DBMET03765 | DBMET03765 | |
| 0.003 | 0.823 | 0.03 | Vasopressin 1 antagonist | 0.03 0.024 DBMET03764 | DBMET03764 | |
| 0.003 | 0.826 | 0.108 | Factor X inhibitor | 0.108 0.009 DBMET03766 | DBMET03766 | |
| 0.004 | 0.829 | 0.077 | HIV-1 integrase (Strand Transfer) inhibitor | 0.077 0.032 DBMET03765 | DBMET03765 | |
| 0.003 | 0.835 | 0.032 | Vasopressin 1A antagonist | 0.032 0.018 DBMET03766 | DBMET03766 | |
| 0.005 | 0.854 | 0.068 | Aminopeptidase microsomal inhibitor | 0.068 0.033 DBMET03766 | DBMET03766 | |
| 0.002 | 0.854 | 0.068 | Growth hormone secretagogue receptor agonist | 0.068 0.014 DBMET03766 | DBMET03766 | |
| 0.05 | 0.904 | 0.327 | Peptidyltransferase inhibitor | 0.327 0.017 DBMET03766 | DBMET03766 | |
| 0.016 | 0.889 | 0.167 | Hepatoprotectant | 0.167 0.093 DBMET03766 | DBMET03766 | |
| 0.004 | 0.884 | 0.048 | Aminopeptidase N inhibitor | 0.048 0.034 DBMET03766 | DBMET03766 | |
| 0.01 | 0.91 | 0.102 | Nav1.4 sodium channel blocker | 0.102 0.073 DBMET03766 | DBMET03766 | |
| 0.005 | 0.919 | 0.24 | Anticoagulant | 0.24 0.041 DBMET03766 | DBMET03766 | |
| 0.004 | 0.921 | 0.078 | Thrombin inhibitor | 0.078 0.044 DBMET03766 | DBMET03766 | |
| 0.004 | 0.933 | 0.123 | Cyclin-dependent kinase inhibitor | 0.123 0.072 DBMET03766 | DBMET03766 | |
| 0.003 | 0.934 | 0.065 | ZAP-70 protein tyrosine kinase inhibitor | 0.065 0.054 DBMET03766 | DBMET03766 | |
| 0.001 | 0.943 | 0.013 | Free fatty acid receptor 2 antagonist | 0.013 0.003 DBMET03766 | DBMET03766 | |
| 0.003 | 0.955 | 0.105 | Cyclin-dependent kinase 2 inhibitor | 0.105 0.064 DBMET03766 | DBMET03766 | |
| 0.004 | 0.959 | 0.105 | HIV-1 reverse transcriptase inhibitor | 0.069 0.05 DBMET03765 0.105 0.028 DBMET03766 | DBMET03766 | |
| 0.004 | 0.964 | 0.042 | GHS receptor antagonist | 0.042 0.01 DBMET03766 | DBMET03766 | |
| 0.003 | 0.967 | 0.205 | Cyclin-dependent kinase 1 inhibitor | 0.205 0.026 DBMET03766 | DBMET03766 | |
| 0.015 | 0.983 | 0.202 | Cyclin-dependent kinase 3 inhibitor | 0.202 0.032 DBMET03766 | DBMET03766 | |
| 0.004 | 0.977 | 0.268 | Toll-Like receptor 7 agonist | 0.268 0.133 DBMET03766 | DBMET03766 | |
| 0.002 | 0.975 | 0.251 | Growth hormone secretagogue receptor antagonist | 0.251 0.004 DBMET03766 | DBMET03766 | |
| 0.004 | 0.978 | 0.284 | Toll-Like receptor agonist | 0.284 0.121 DBMET03766 | DBMET03766 | |
| 0.004 | 0.98 | 0.202 | CDK3/cyclin E inhibitor | 0.202 0.006 DBMET03766 | DBMET03766 | |
| 0.003 | 0.981 | 0.482 | Lipase inhibitor | 0.482 0.002 DBMET03766 | DBMET03766 | |
| 0.005 | 0.985 | 0.32 | Angiogenesis stimulant | 0.32 0.042 DBMET03766 | DBMET03766 | |
| 0.002 | 0.986 | 0.054 | CDK9/cyclin T1 inhibitor | 0.054 0.046 DBMET03766 | DBMET03766 | |
| 0.003 | 0.987 | 0.196 | CDK1/cyclin B1 inhibitor | 0.196 0.009 DBMET03766 | DBMET03766 | |
| 0.003 | 0.99 | 0.097 | Protein kinase C mu inhibitor | 0.097 0.06 DBMET03764 | DBMET03764 | |
| 0.003 | 0.992 | 0.105 | Platelet activating factor antagonist | 0.105 0.074 DBMET03766 | DBMET03766 | |
| 0.005 | 0.995 | 0.093 | Hematopoietic | 0.093 0.044 DBMET03765 | DBMET03765 | |
| 0.005 | 0.995 | 0.091 | Toll-Like receptor 4 antagonist | 0.091 0.087 DBMET03766 | DBMET03766 | |
| 0.004 | 0.995 | 0.217 | Platelet aggregation inhibitor | 0.217 0.069 DBMET03766 | DBMET03766 | |
| 0.002 | 0.996 | 0.16 | Aminoacyl-tRNA synthetase inhibitor | 0.16 0.016 DBMET03766 | DBMET03766 | |
| 0.002 | 0.995 | 0.495 | Kinesin antagonist | 0.495 0.001 DBMET03766 | DBMET03766 | |
| 0.002 | 0.995 | 0.495 | Kinesin-like protein 1 inhibitor | 0.495 0.001 DBMET03766 | DBMET03766 | |
| 0.002 | 0.996 | 0.089 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.089 0.05 DBMET03766 | DBMET03766 | |
| 0.001 | 0.996 | 0.077 | CDK2/cyclin E2 inhibitor | 0.077 0.041 DBMET03766 | DBMET03766 | |
| 0.001 | 0.996 | 0.088 | Leukotriene A4 hydrolase inhibitor | 0.088 0.007 DBMET03766 | DBMET03766 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |